Eli Lilly and Company
RAPID-ACTING INSULIN COMPOSITIONS
Last updated:
Abstract:
The invention is a composition of insulin or insulin analog that has faster pharmacokinetic action than commercial formulations of rapid-onset insulin analog products.
Status:
Application
Type:
Utility
Filling date:
31 May 2018
Issue date:
12 Mar 2020